IP Library Patent Application 16286707
Patent Application
App. No. 16/286,707

DEVICES AND METHODS FOR PERCUTANEOUS LUNG INTRATUMORAL THERAPY DELIVERY

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
16/286,707
Abstract

Percutaneous therapy or drug delivery devices are described herein. The device can include one or multiple lumens inside a cannula or catheter body. The device can include features for reducing or preventing backflow or reflux of infusate along the device insertion track, such as one or more bullet noses, over tubes, and/or micro-tips. The device can be used in any of a variety of treatment methods, including to inject cancer therapy medicinal products directly into pulmonary tumors or tumors located in other regions of the body. The device can include features to keep the distal tip secure during patient respiration or during other patient movement, and can reduce the incidence of reflux during therapy delivery.

Claims (14)

1 . A drug delivery device, comprising:

a distal tip having one or more fluid ports therein;

an inner fluid lumen configured to convey fluid to the one or more fluid ports of the tip; and

a plurality of bullet noses disposed in a spaced relationship along a length of the device proximal to the distal tip.

2 . The device of claim 1 wherein the plurality of bullet noses are configured to limit or prevent backflow of infusate along an exterior of the device.

3 . The device of claim 1 , further comprising means for anchoring the distal tip to target tissue of a patient to prevent movement of the distal tip relative to the target tissue during patient movement, wherein the means for anchoring is separate from the plurality of bullet noses.

4 . The device of claim 3 , wherein the target tissue of a patient comprises a tumor.

5 . The device of claim 3 , wherein the patient movement comprises respiration.

6 . The device of claim 1 , wherein the device includes one or more over-tubes disposed over the distal tip to define a tissue-receiving space.

7 . The device of claim 6 , wherein tissue is received within the tissue-receiving space to limit or prevent backflow of infusate along an exterior of the device.

8 . The device of claim 1 , wherein one or more of the plurality of bullet noses have a conical, curved, or tapered exterior surface.

9 . The device of claim 1 , wherein the plurality of bullet noses engage surrounding tissue to anchor the device.

10 . The device of claim 3 , wherein the means for anchoring comprises one or more splines deployable from an exterior of the device to engage surrounding tissue.

11 . The device of claim 3 , wherein the means for anchoring comprises one or more balloons deployable from an exterior of the device to engage surrounding tissue.

Assignments (1)
CHANGE OF NAME Recorded Jan 13, 2022
From: ALCYONE LIFESCIENCES, INC.
To: ALCYONE THERAPEUTICS, INC.
Reel/Frame 058734/0707 →